Cite
HARVARD Citation
Wang, Q. et al. (n.d.). Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF‐beta signal. Journal of surgical oncology. 107 (4), pp. 422-427. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, Q. et al. (n.d.). Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF‐beta signal. Journal of surgical oncology. 107 (4), pp. 422-427. [Online].